Endurant® II ETBF2313C124ERecalls & reported problems
Medtronic, Inc. · STENT GRAFT ETBF2313C124E ENDUR II BIF · Class 3 · Implant
All models of Endurant II (114)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 7
- Deaths reported
- 3
- Injuries reported
- 3
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00613994991164), received between Feb 8, 2017 and Aug 25, 2025 — classified as 3 deaths, 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Difficult to Advance” (1 report).
2 FDA recall records name this device's identifier, 1 still open.
5 other recalls cover devices cleared under the same FDA submission (P100021); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Dec 21, 2021Class IIOpen, Classified
Stent Graft Systems built with specific batches of taper tip assemblies have the potential for the taper tip to detach from the delivery system. Detachment of the taper tip during the implant procedure may lead to a secondary intervention to attempt to remove the taper tip, either by endovascular retrieval or surgical conversion. There is also potential that the taper tip is intentionally left behind in the patient, at the physician's discretion, if not easily removable.
Z-0657-2022 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
- Feb 27, 2017Class IITerminated
Medtronic is initiating a voluntary Urgent Medical Device Recall for a subset of Endurant/ Endurant II Bifurcated Stent Graft Systems of specific models and serial numbers as this specific subset of stent grafts has greater susceptibility to fabric permeability variations that may be associated with endoleaks observed during the initial implant procedure.
Z-1543-2017 · Root cause: Packaging change control · Recall details · FDA record ↗
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
- Difficult to Advance1
- Difficult to Remove1
- Leak/Splash1
- Occlusion Within Device1
Patient problems
- Ischemia2
- Rupture2
- Claudication1
- Death1
- Embolism/Embolus1
- Low Blood Pressure/ Hypotension1
- No Clinical Signs, Symptoms or Conditions1
- Obstruction/Occlusion1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 25, 2025Difficult to Remove; Difficult to Remove
IT WAS REPORTED THAT DURING AN ENDOVASCULAR AORTIC REPAIR PROCEDURE USING A STENT GRAFT ETBF2313C124E ENDUR II BIF AND BILATERAL LIMBS TO TREAT A 63 MM ANEURYSM, DIFFICULTIES WERE ENCOUNTERED DURING REMOVAL OF THE MAIN BODY STENT GRAFT'S DELIVERY SYSTEM. AFTER DEPLOYMENT OF THE MAIN BODY, THE DELIVERY SYSTEM COULD NOT BE BACKED OUT OVER THE WIRE. WHILE ADVANCING THE DELIVERY SYSTEM BACK INTO THE COMMON FEMORAL ARTERY, A KINK IN THE WIRE WAS IDENTIFIED. THE WIRE WAS THEN CUT PROXIMAL TO THE KINK, ALLOWING THE DELIVERY SYSTEM TO BE REMOVED WITH MINOR DIFFICULTY. NO PATIENT COMPLICATIONS WERE ASSOCIATED WITH THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22883367 ↗DeathFeb 27, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AN ENDURANT II BIFURCATE STENT GRAFT SYSTEM WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A 53MM SACCULAR AAA . IT WAS REPORTED DURING THE PROCEDURE, AFTER IMPLANTING THE MAIN BODY AND A LIMB, THE PHYSICIAN BEGAN VERY LIGHTLY BALLOONING THE PROXIMAL NECK SEAL ZONE. WHILE BALLOONING THERE WAS A CHANGE IN DIAMETER OF THE PROXIMAL NECK AND A RUPTURE WAS CONFIRMED. THE PATIENTS BLOOD PRESSURE DROPPED AND SUSTAINED BALLOON INFLATION WAS USED TO MAINTAIN SYSTOLIC PRESSURE. THE PHYSICIAN THEN OBTAINED LEFT ARM ACCESS AND USED A CHIMNEY TECHNIQUE TO PLACE A NON MDT STENT INTO THE LEFT RENAL ARTERY AND SUBSEQUENTLY PLACED A 25/25/49 AORTIC CUFF TO THE LEVEL OF THE RIGHT RENAL ARTERY. AFTER BALLOONING, THE CUFF HELPED SLOW THE EXTRAVASATION IN THE PROXIMAL NECK BUT THE PATIENT CONTINUED TO BE UNSTABLE AND THE PATIENT WAS CONVERTED TO AN OPEN SURGICAL REPAIR. PER THE PHYSICIAN THE CAUSE OF THE RUPTURE WAS DUE TO VERY FRIABLE AND CALCIFIED TISSUE IN THE PROXIMAL SEAL ZONE. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Ischemia; Low Blood Pressure/ Hypotension; Rupture; Thrombosis/Thrombus
MAUDE report 16442062 ↗InjuryJan 24, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED DURING AN UNKNOWN ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED APPROXIMATELY 6 MONTHS POST THE INDEX PROCEDURE FOLLOW UP CT SHOWED THE PATIENT LOST FLOW TO THE LIMB DUE TO OUTFLOW ISSUES. INTERVENTION WITH A FEM CROSSOVER GRAFT WAS PERFORMED AND THE OCCLUSION RESOLVED. PER THE PHYSICIAN THE CAUSE OF THE OCCLUSION WAS AS THE EXTERNAL ILIAC WAS DISEASED AND NOTED THAT THE GRAFT WAS NOT KINKED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Obstruction/Occlusion
MAUDE report 16234005 ↗DeathMay 26, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN THE PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN AORTIC ULCER. IT WAS STATED THAT THE PATIENT WAS THROWING THROMBUS BEFORE THE INITIAL PROCEDURE. PATIENT UNDERWENT EVAR TO PREVENT THROMBUS FROM THE INFRARENAL AORTA FROM CONTINUING TO BREAK OFF AND CAUSE ISCHEMIA IN HER LOWER EXTREMITIES. IT WAS REPORTED THAT THE PATIENT WAS DISCHARGED ON THE NEXT DAY POST INDEX PROCEDURE, HOWEVER, THE PATIENT RETURNED TO THE HOSPITAL ON THE NEXT DAY POST DISCHARGE WITH ABDOMINAL PAIN. IT WAS STATED THAT THE PATIENT WAS ADMITTED AND TAKEN TO SURGERY FOR AN ISCHEMIC RIGHT COLON. PATIENT DIED APPROXIMATELY 1 WEEKS POST INDEX PROCEDURE. AS PER THE PHYSICIAN, CAUSE OF THE EVENT WAS BOWEL ISCHEMIA. THE PHYSICIAN STATED THAT THROMBUS WENT INTO THE SMA CAUSING THE RIGHT COLON ISCHEMIA. THE PHYSICIAN STATED THAT WIRE MANIPULATION COULD HAVE LEAD TO MORE THROMBUS GOING INTO THE SMA. THE PHYSICIAN DOES NOT BELIEVE THAT THE DEVICE LEAD TO THE COMPLICATION DUE TO IT BEING THE RIGHT COLON NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT EXPIRED.
Patient problems: Embolism/Embolus; Ischemia; Pain
MAUDE report 11886274 ↗InjuryOct 15, 2018Leak/Splash; Leak/Splash
AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 66MM ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THE PATIENT PRESENTED EMERGENTLY NEARLY SIX YEARS LATER WITH A TYPE IA AND IB ENDOLEAK THAT HAD LED TO A RUPTURED ANEURYSM. AN EMERGENCY INTERVENTION PROCEDURE WAS CARRIED OUT THE FOLLOWING DAY AND AN AORTIC CUFF, BILATERAL RENAL SNORKELS, ENDOANCHORS AND BILATERAL LIMB EXTENSIONS WERE IMPLANTED. THE EVENT IS REPORTED TO BE RESOLVED. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT IS UNKNOWN. NO ADDITIONAL SEQUELAE WERE REPORTED, AND THE PATIENT IS FINE.
Patient problems: Rupture
MAUDE report 7964702 ↗DeathJun 28, 2018Difficult to Advance; Difficult to Advance
AN ENDURANT II STENT GRAFT SYSTEM WAS PLANNED TO BE IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 50MM ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT DURING THE INDEX PROCEDURE THE PHYSICIAN ATTEMPTED TO INTRODUCE THE BIFURCATED STENT GRAFT ETBF2313C124E THOUGHT THE LEFT EXTERNAL ILIAC BUT WAS UNSUCCESSFUL. IT WAS REPORTED THAT THE PHYSICIAN THEN PRE-DILATED THE LEFT EXTERNAL ILIAC WITH A NON MDT 8X40 PTA BALLOON AND IT WAS THOUGHT THAT AN ILIAC TEAR OCCURRED AT THIS POINT. THE PHYSICIAN WAS STILL UNABLE TO ADVANCE THE BIFURCATED STENT GRAFT DELIVERY SYSTEM THROUGH THE EXTERNAL ILIAC. THE PHYSICIAN REMOVED THE DELIVERY SYSTEM AND PLACED A 14F SHEATH TO ACHIEVE HAEMOSTASIS IN THE ARTERIOTOMY. THE PHYSICIAN THEN ATTEMPTED TO BALLOON THE LEFT EXTERNAL ILIAC WITH A 10MM PTA BALLOON. UPON REMOVING THE CONTRAST FROM THE PTA BALLOON, THE ANAESTHESIOLOGIST STATED THAT THE BLOOD PRESSURE WAS DROPPING. THE PHYSICIAN THEN ADVANCED THE 14F SHEATH INTO THE DISTAL AORTA AND THEN PLACED AN ENDURANT II ILIAC EXTENSION STENT GRAFT ETEW1010C82E INTO THE SHEATH. AFTER POSITIONING THE SHEATH DISTAL TO THE ILIAC TEAR, THE PHYSICIAN DEPLOYED THE STENT GRAFT. THE PHYSICIAN STATED THAT THE B
Patient problems: Death; Perforation of Vessels
MAUDE report 7645505 ↗InjuryFeb 8, 2017Occlusion Within Device; Occlusion Within Device
AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 48MM IN DIAMETER ABDOMINAL AORTIC ANEURYSM. THE PROXIMAL NECK WAS 18-17MM IN DIAMETER AND 45MM IN LENGTH. THE RIGHT ILIAC ARTERIES MEASURED 10-11MM IN DIAMETER AND THE LEFT ILIAC ARTERIES MEASURED 10-9-11MM IN DIAMETER. IT WAS REPORTED THAT THERE WAS LEFT LIMB OCCLUSION AND THE PATIENT HAD CLAUDICATION STARTING AT THE LEFT BUTTOCK. THE PHYSICIAN ELECTED TO PERFORM A FEMORAL TO FEMORAL BYPASS AND THE EVENT WAS RESOLVED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Claudication; Occlusion
MAUDE report 6312658 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P100021. One submission often covers many models, so check the product and lot details in each record.
- Z-0292-2022 · Oct 15, 2021 · Open, ClassifiedEndurant IIs Stent Graft System REF/Description: ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STEN
- Z-0291-2022 · Oct 15, 2021 · Open, ClassifiedEndurant II Stent Graft System REF/Description: ETBF2513C145EE STENT GRAFT ETBF2513C145EE ENDUR II BIF ETBF2820C166EE STENT GRAFT ETBF2820C166EE ENDUR II BIF ETBF2820C166EE STENT G
- Z-0290-2022 · Oct 15, 2021 · Open, ClassifiedEndurant Stent Graft System REF/Description: ENTF2525C70EE STENT GRAFT ENTF2525C70EE ENDURANT TUBE
- Z-2135-2021 · Jun 7, 2021 · Open, ClassifiedEndurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infra
- Z-2136-2021 · Jun 7, 2021 · Open, ClassifiedMedtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aortoili
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page